EP3355891
PACRITINIB FOR USE IN TREATING TRANSPLANT REJECTION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.9.2016EP published:
13.1.2021EP application number:
16852514.5
EPO information:
European Patent Register
Max expiry date:
27.9.2036
Title:
PACRITINIB FOR USE IN TREATING TRANSPLANT REJECTION
Timeline
Today
28.9.2016EP application
13.1.2021EP Publication
Owner
Name:
CTI Biopharma Corp.Address:
3101 Western Avenue 600, Seattle, Washington 98121, US
Inventor
Name:
BETTS, Brian C.Address:
Seattle, Washington 98121, US
Name:
YU, XuezhongAddress:
Seattle, Washington 98121, US
Name:
ANASETTI, ClaudioAddress:
Seattle, Washington 98121, US
Priority
Number:
201562233715 PDate:
28.9.2015Country:
US
Classification
Categories:
A61K 31/529, A61K 31/519, A61K 31/5355, A61K 31/56, A61K 39/395, A61K 45/06, A61P 37/06